DHDDS-Congenital Disorder of Glycosylation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which DHDDS-Congenital Disorder of Glycosylation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 1

NCT07572825

Assessing the Safety and Tolerability of NMN in DHDDS-CDG

The primary objective of this study is to evaluate the safety and tolerability of the dietary supplement, nicotinamide mononucleotide (NMN), in individuals with…

United States8 participantsStarted 2026-06-01

Treatment: Nicotinamide Mononucleotide (NMN) Nucleosidase